374 related articles for article (PubMed ID: 8681386)
1. Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid.
Sintchak MD; Fleming MA; Futer O; Raybuck SA; Chambers SP; Caron PR; Murcko MA; Wilson KP
Cell; 1996 Jun; 85(6):921-30. PubMed ID: 8681386
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure at 2.4 A resolution of Borrelia burgdorferi inosine 5'-monophosphate dehydrogenase: evidence of a substrate-induced hinged-lid motion by loop 6.
McMillan FM; Cahoon M; White A; Hedstrom L; Petsko GA; Ringe D
Biochemistry; 2000 Apr; 39(15):4533-42. PubMed ID: 10758003
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of a ternary complex of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: NAD+ orients the active site loop for catalysis.
Gan L; Petsko GA; Hedstrom L
Biochemistry; 2002 Nov; 41(44):13309-17. PubMed ID: 12403633
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of Tritrichomonasfoetus inosine monophosphate dehydrogenase in complex with substrate, cofactor and analogs: a structural basis for the random-in ordered-out kinetic mechanism.
Prosise GL; Luecke H
J Mol Biol; 2003 Feb; 326(2):517-27. PubMed ID: 12559919
[TBL] [Abstract][Full Text] [Related]
5. Species-specific inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid.
Digits JA; Hedstrom L
Biochemistry; 1999 Nov; 38(46):15388-97. PubMed ID: 10563825
[TBL] [Abstract][Full Text] [Related]
6. The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.
Sintchak MD; Nimmesgern E
Immunopharmacology; 2000 May; 47(2-3):163-84. PubMed ID: 10878288
[TBL] [Abstract][Full Text] [Related]
7. Bacillus anthracis inosine 5'-monophosphate dehydrogenase in action: the first bacterial series of structures of phosphate ion-, substrate-, and product-bound complexes.
Makowska-Grzyska M; Kim Y; Wu R; Wilton R; Gollapalli DR; Wang XK; Zhang R; Jedrzejczak R; Mack JC; Maltseva N; Mulligan R; Binkowski TA; Gornicki P; Kuhn ML; Anderson WF; Hedstrom L; Joachimiak A
Biochemistry; 2012 Aug; 51(31):6148-63. PubMed ID: 22788966
[TBL] [Abstract][Full Text] [Related]
8. Allosteric properties of inosine monophosphate dehydrogenase revealed through the thermodynamics of binding of inosine 5'-monophosphate and mycophenolic acid. Temperature dependent heat capacity of binding as a signature of ligand-coupled conformational equilibria.
Bruzzese FJ; Connelly PR
Biochemistry; 1997 Aug; 36(34):10428-38. PubMed ID: 9265623
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of human type II inosine monophosphate dehydrogenase: implications for ligand binding and drug design.
Colby TD; Vanderveen K; Strickler MD; Markham GD; Goldstein BM
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3531-6. PubMed ID: 10097070
[TBL] [Abstract][Full Text] [Related]
10. IMP dehydrogenase : structural aspects of inhibitor binding.
Goldstein BM; Colby TD
Curr Med Chem; 1999 Jul; 6(7):519-36. PubMed ID: 10390598
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of mycophenolic acid-resistant mutants of inosine-5'-monophosphate dehydrogenase.
Farazi T; Leichman J; Harris T; Cahoon M; Hedstrom L
J Biol Chem; 1997 Jan; 272(2):961-5. PubMed ID: 8995388
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of IMPDH by mycophenolic acid: dissection of forward and reverse pathways using capillary electrophoresis.
Fleming MA; Chambers SP; Connelly PR; Nimmesgern E; Fox T; Bruzzese FJ; Hoe ST; Fulghum JR; Livingston DJ; Stuver CM; Sintchak MD; Wilson KP; Thomson JA
Biochemistry; 1996 Jun; 35(22):6990-7. PubMed ID: 8679523
[TBL] [Abstract][Full Text] [Related]
13. Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy.
Vethe NT; Bergan S
Ther Drug Monit; 2006 Oct; 28(5):608-13. PubMed ID: 17038874
[TBL] [Abstract][Full Text] [Related]
14. The immunosuppressive agent mizoribine monophosphate forms a transition state analogue complex with inosine monophosphate dehydrogenase.
Gan L; Seyedsayamdost MR; Shuto S; Matsuda A; Petsko GA; Hedstrom L
Biochemistry; 2003 Feb; 42(4):857-63. PubMed ID: 12549902
[TBL] [Abstract][Full Text] [Related]
15. Effect of mycophenolic acid glucuronide on inosine monophosphate dehydrogenase activity.
Nowak I; Shaw LM
Ther Drug Monit; 1997 Jun; 19(3):358-60. PubMed ID: 9200779
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and crystal structure of bacterial inosine-5'-monophosphate dehydrogenase.
Zhang R; Evans G; Rotella FJ; Westbrook EM; Beno D; Huberman E; Joachimiak A; Collart FR
Biochemistry; 1999 Apr; 38(15):4691-700. PubMed ID: 10200156
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolic acid analogs with a modified metabolic profile.
Chen L; Wilson DJ; Labello NP; Jayaram HN; Pankiewicz KW
Bioorg Med Chem; 2008 Oct; 16(20):9340-5. PubMed ID: 18809333
[TBL] [Abstract][Full Text] [Related]
18. Cofactor-type inhibitors of inosine monophosphate dehydrogenase via modular approach: targeting the pyrophosphate binding sub-domain.
Felczak K; Chen L; Wilson D; Williams J; Vince R; Petrelli R; Jayaram HN; Kusumanchi P; Kumar M; Pankiewicz KW
Bioorg Med Chem; 2011 Mar; 19(5):1594-605. PubMed ID: 21324702
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics of mycophenolic acid in CD4+ cells: a single-dose study of IMPDH and purine nucleotide responses in healthy individuals.
Vethe NT; Bremer S; Rootwelt H; Bergan S
Ther Drug Monit; 2008 Dec; 30(6):647-55. PubMed ID: 18806697
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolic acid and thiazole adenine dinucleotide inhibition of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: implications on enzyme mechanism.
Hedstrom L; Wang CC
Biochemistry; 1990 Jan; 29(4):849-54. PubMed ID: 1971185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
